IDB-011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDB-011, covering 2026-03-25 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 [Phase 1]